Occipital Nerve Blocks and Trigger Point Injections for Headache Management

Indications and Frequency

The 2023 VA/DoD guidelines recommend occipital nerve blocks can be repeated every 3 months up to 3 times, with a "weak for" recommendation for abortive migraine treatment, based on low-quality evidence showing improvement versus placebo 1
The American College of Internal Medicine suggests that occipital nerve blocks should not be scheduled prophylactically without first establishing efficacy with a single treatment, and should be repeated at 3-month intervals when pain recurs, not monthly 1
If effective, but pain recurs, blocks can be repeated at 3-month intervals up to 3 times, as recommended by the VA/DoD guidelines 1

A single diagnostic/therapeutic occipital nerve block should be performed first to assess response before committing to a series, with a trial of a single occipital nerve block (bilateral greater occipital nerves) with local anesthetic plus corticosteroid, and assessment of response at 2-4 weeks 1
If refractory after 3 properly-spaced blocks, consideration of referral to neurosurgery for occipital nerve stimulation evaluation is recommended, according to the Congress of Neurological Surgeons 2

Detailed medication trial history, including specific medications tried, dosages, duration of trials, and reasons for discontinuation, is necessary before approval, as recommended by the American College of Internal Medicine 1
Functional impact, including headache frequency, disability scores, and impact on daily activities, should be documented, as suggested by the VA/DoD guidelines 1

The American College of Physicians, as referenced in the Annals of Internal Medicine, classifies occipital nerve block for the treatment of occipital neuralgia as experimental and investigational because the effectiveness of this approach has not been established, superseding clinical evidence considerations for coverage determination purposes 3, 4

The Congress of Neurological Surgeons recommends greater occipital nerve blocks as first-line treatment for occipital neuralgia before considering advanced interventions like occipital nerve stimulation, according to Praxis Medical Insights 3
The 2023 VA/DoD Clinical Practice Guidelines for Headache Management do not address occipital nerve blocks specifically for occipital neuralgia, but discuss greater occipital nerve blocks for migraine treatment with a weak recommendation, as reported in the Annals of Internal Medicine 4, 5

Aetna's policy explicitly lists "occipital nerve block for the treatment of occipital neuralgia" under experimental and investigational procedures, which is a categorical exclusion regardless of clinical circumstances or supporting evidence, as stated in Praxis Medical Insights and the Annals of Internal Medicine 3, 4

The American College of Internal Medicine recommends against monthly scheduling of occipital nerve blocks, requiring 3-month intervals when pain recurs, to prevent medication-overuse headache, with a strength of evidence based on clinical guidelines 6, 7
Research suggests that combined occipital nerve block plus trigger point injection is superior to either alone, but only when there are documented active cervical myofascial trigger points, with a significant reduction in migraine days, according to the Annals of Internal Medicine 7
The use of migraine-specific abortive therapy, such as triptans or DHE, is recommended for acute attacks, and preventive migraine therapy should be optimized to reduce attack frequency, as suggested by the Annals of Internal Medicine 7
Metoclopramide IV can be used for acute attacks with nausea, as part of a comprehensive treatment plan, based on evidence from the Annals of Internal Medicine 6, 7

Migraine-specific abortive therapy, such as triptans or DHE, should be optimized for acute attacks, with a strength of evidence based on clinical guidelines 7
Preventive migraine therapy should be used to reduce attack frequency, especially given the risk of medication-overuse headache with frequent interventional procedures, as recommended by the Annals of Internal Medicine 7
NSAIDs, such as ibuprofen, or acetaminophen can be used for short-term relief, as part of a comprehensive treatment plan, based on evidence from the Annals of Internal Medicine 7